secwatch / observer
8-K filed Jun 13, 2025 23:59 UTC ticker SRXH CIK 0001471727
leadership confidence high sentiment neutral materiality 0.73

SRx Health Solutions appoints new CEO, President, Chairman and CFO

SRx Health Solutions, Inc.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Davender Sohi

President
SRXH · SRx Health Solutions, Inc.
Effective
2025-06-10
Successor
Kent Cunningham
Filed
Jun 13, 2025 23:59 UTC
On June 10, 2025, SRx Health Solutions, Inc. (the “ Company ”) accepted the voluntary resignation of Davender Sohi as the President of the Company, effective immediately.
Appointed

Adesh Vora

Chief Executive Officer
SRXH · SRx Health Solutions, Inc.
Effective
2025-06-11
Filed
Jun 13, 2025 23:59 UTC
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Appointed

Kent Cunningham

President
SRXH · SRx Health Solutions, Inc.
Effective
2025-06-11
Filed
Jun 13, 2025 23:59 UTC
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Appointed

Lionel Conacher

Chairman of the Board
SRXH · SRx Health Solutions, Inc.
Effective
2025-06-11
Filed
Jun 13, 2025 23:59 UTC
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Source: SEC EDGAR
accession 0001641172-25-015024

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.